http:\/\/worldheartday.org<\/a>.<\/p>\nWorld Heart Day is proud to be supported by AstraZeneca, Boehringer Ingelheim and Lilly Alliance, and Pfizer<\/strong><\/p>\nJoris Silon, Senior Vice President, Cardiovascular, Renal and Metabolism, AstraZeneca<\/strong>, said:\u00a0\u201cCardiovascular diseases, including serious conditions like heart failure and stroke, are the world\u2019s leading cause of death and the burden continues to increase each year. In the midst of the COVID-19 pandemic, these patients are at an even higher risk of severe outcomes and complications. We are proud to partner with the World Heart Federation to improve awareness of these conditions and risk factors and help save lives through prevention, earlier diagnosis, and enhanced disease management.\u201d<\/p>\nSuneet Varma, Global President, Rare Disease, Pfizer<\/strong> said: \u201cDuring these unprecedented times, it\u2019s critical that we \u2018Use Heart\u2019 to continue to pioneer innovation, champion health equity and improve care for all of those impacted by heart diseases, including rare and underrecognized heart conditions. We\u2019re proud to continue our partnership with the World Heart Federation for World Heart Day and support their efforts to unite stakeholders around the world to\u00a0beat cardiovascular disease.\u201d<\/p>\nLeonard Glass, Vice President of Global Medical Affairs, Eli Lilly\u00a0and Company<\/strong>, said:\u00a0\u201c<\/strong>World Heart Day is a pivotal moment each year to highlight the importance of heart health and the need to continue to improve outcomes for patients with cardiovascular disease, with and without type 2 diabetes. We are proud to be part of the World Heart Federation\u2019s network in creating global momentum to help achieve this. Lilly, in partnership with Boehringer Ingelheim, is dedicated\u00a0to supporting\u00a0patients and healthcare providers during\u00a0the COVID-19 pandemic and beyond\u00a0by\u00a0advancing treatments and pioneering research. Together we can address global public health challenges driven by the cardiovascular, renal and metabolic diseases, restoring balance between these systems.\u201d<\/p>\nWaheed Jamal, Corporate Vice President and Head of Cardiometabolic Medicine, Boehringer Ingelheim<\/strong>, said:\u201cWorld Heart Day shines a powerful light on the vital importance of good cardiovascular health, and Boehringer Ingelheim,\u00a0in partnership with Lilly, is proud to be continuing to\u00a0support\u00a0the World Heart\u00a0Federation in these\u00a0efforts. People\u00a0with diabetes are twice as likely to have heart failure than those without, and one in two people with type 2 diabetes worldwide die of a cardiovascular event. Recent findings indicate COVID-19 poses a higher risk for people\u00a0living\u00a0with\u00a0cardio-renal-metabolic conditions,\u00a0so this year World Heart Day is even more significant in\u00a0demonstrating the importance of supporting\u00a0these patients. The Boehringer Ingelheim and Lilly Alliance is committed to improving the lives of people living with cardiovascular disease, its associated conditions, and in understanding the interconnection of the heart, kidneys, and metabolic systems.\u201d<\/p>\nMedia Contact \n<\/strong>Borjana Pervan \nCommunications Director \nWorld Heart Federation \nBorjana.pervan@worldheart.org<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"The COVID-19 pandemic is creating a perfect storm for heart health. Three main factors are contributing to this phenomenon. First, people with COVID-19 and heart disease are among those with the highest risk of death and of developing severe conditions. Second, after the virus attacks, the heart might be adversely affected even in people without […]<\/p>\n","protected":false},"featured_media":8797,"template":"","meta":{"_acf_changed":false,"_relevanssi_hide_post":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"","_relevanssi_noindex_reason":"","footnotes":""},"event":[],"project-campaign":[314],"topic":[],"class_list":["post-8796","news","type-news","status-publish","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"\n
Perfect storm for heart disease created by the COVID-19 crisis - World Heart Federation<\/title>\n \n \n \n \n \n \n \n \n \n \n\t \n\t \n\t \n \n \n\t \n